breast-cancer

Documents about breast-cancer

• MUC1 Vaccine for Triple-negative Breast Cancer#172406ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer#127672ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Metastatic Breast Cancer#366652ClinicalTrials.gov
• TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer#268031ClinicalTrials.gov
• VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study#67874ClinicalTrials.gov
• Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer#314405ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer#290842ClinicalTrials.gov
• I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer#245486ClinicalTrials.gov
• HER2 Vaccine for Locally Advanced Breast Cancer#148563ClinicalTrials.gov
• Combination Study of SV-BR-1-GM With Retifanlimab#234415ClinicalTrials.gov
• Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases#158220ClinicalTrials.gov
• Neoadjuvant, SBRT With Intratumoural Pembrolizumab Followed by Neoadjuvant Chemotherapy in Breast Cancer#366590ClinicalTrials.gov
• Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer#184852ClinicalTrials.gov
• Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab#217005ClinicalTrials.gov
• Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer#307438ClinicalTrials.gov
• Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)#261467ClinicalTrials.gov
• Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer#136261ClinicalTrials.gov
• Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus Chemotherapy#234433ClinicalTrials.gov
• Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer#184853ClinicalTrials.gov
• Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer#307441ClinicalTrials.gov
• Exercise and Metformin in Colorectal and Breast Cancer Survivors#267982ClinicalTrials.gov
• Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative#158196ClinicalTrials.gov
• Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer#181765ClinicalTrials.gov
• A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer#353297ClinicalTrials.gov
• Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer#349969ClinicalTrials.gov
• STRIDE - STimulating Immune Response In aDvanced brEast Cancer#143670ClinicalTrials.gov
• Exercise in Triple- Negative Breast Cancer#268004ClinicalTrials.gov
• Immunotherapy in Treating Patients With Metastatic Breast Cancer#287401ClinicalTrials.gov
• Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast Cancer#238099ClinicalTrials.gov
• Autologous Vaccination With Lethally Irradiated, Autologous Breast Cancer Cells Engineered to Secrete GM-CSF in Women With Operable Breast Cancer#195389ClinicalTrials.gov
• Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)#143571ClinicalTrials.gov
• Stress-Reducing Intervention in Patients With Colorectal and Breast Cancer#152428ClinicalTrials.gov
• HER-2 Protein Vaccine in Treating Women With Breast Cancer#279555ClinicalTrials.gov
• Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer#300271ClinicalTrials.gov
• RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer#208254ClinicalTrials.gov
• Vaccination With Autologous Breast Cancer Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Metastatic Breast Cancer Patients#148561ClinicalTrials.gov
• The Effect of Metformin on Breast Cancer Patients#201754ClinicalTrials.gov
• Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer#268026ClinicalTrials.gov
• Reverse Triple Negative Immune Resistant Breast Cancer#325309ClinicalTrials.gov
• Breast cancer in pregnancy: concurrent cesarean section, nipple-sparing mastectomy, and immediate breast reconstruction-case report#250569IRIS
• Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer#283025ClinicalTrials.gov
• Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors#67858ClinicalTrials.gov
• Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients#346907ClinicalTrials.gov
• Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1)#283084ClinicalTrials.gov
• A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer#366654ClinicalTrials.gov
• The Impact of Obesity and Obesity Treatments on Breast Cancer#18559ClinicalTrials.gov
• Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer#28322ClinicalTrials.gov
• SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC)#121344ClinicalTrials.gov
• Vaccine Therapy in Treating Women With Previously Treated Metastatic Breast Cancer#184908ClinicalTrials.gov
• Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy#123570ClinicalTrials.gov

Related topics